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Introduction: Juxtarenal aneurysms after previous surgical aortic reconstruction constitute a complex clinical scenario.
Open redo surgery is technically demanding and usually requires suprarenal or supraceliac clamping. Standard endo-
vascular repair is prohibited due to the lack of a proximal landing zone. We present our experience with fenestrated
endovascular aneurysm repair (F-EVAR) in the treatment of juxtarenal aneurysms after previous open surgery.
Methods: A prospectively maintained database including all patients with juxtarenal abdominal aortic aneurysm after
previous surgical reconstruction that underwent F-EVAR within the period from November 2003 to February 2013
under the instruction of the senior author. Evaluated outcomes included initial technical success and operative mortality
and morbidity as well as late survival, target vessel patency, aneurysm diameter regression, renal function, and
reintervention.
Results: A total of 35 patients (33 male; mean age, 71.5 6 6.2 years) were treated. Median interval from the primary
surgical reconstruction was 126 months (range, 48-223 months). All patients had proximal anatomies precluding
standard endovascular techniques and were considered high risk for open repair due to their comorbidities and redo
nature of the operation. In total, 111 vessels were targeted: 77 with small fenestrations, 33 with scallops, and 1 vessel with
a downward branch. The operation was completed by totally endovascular means in 34 patients (97.1%). In one patient,
a retroperitoneal approach was needed to gain retrograde access to a renal artery. Operative target vessel perfusion success
rate was 100%. Operative mortality was 0% and median hospital stay 6 days (range, 2-40 days). Mean follow-up (FU) was
37.5 6 25 months. Mean aneurysm maximal diameter decreased from 60 6 4 mm to 47 6 8 mm (P < .05). No type I
endoleak was diagnosed, and no reintervention was required during FU. There were eight late deaths, all unrelated to the
aneurysm. Estimated survival rates at 1, 2, and 4 years were 92.0%6 5.5%, 82.8%6 7.9% and 76.9%6 9.3%, respectively.
Three target vessel occlusions occurred during FU. One patient suffered a bilateral renal artery occlusion resulting in
dialysis. In a second patient, one renal artery occluded without clinical symptoms. No other cases of renal function
deterioration were observed.
Conclusions: F-EVAR is a valid treatment option for juxtarenal aneurysms after previous surgical reconstruction. F-EVAR
represents a less morbid alternative to redo open surgery, has a high technical success rate, and shows durability in mid-
term FU. (J Vasc Surg 2014;59:307-14.)1-3Open infrarenal aortic reconstruction can be compli-
cated by proximal para-anastomotic aneurysms (PAAs) or
progressive aneurysmal degeneration of the native aorta.
These complications are uncommon and usually appear
years after the initial operation but constitute a challenging
clinical scenario.
Open repair is technically demanding and often req-
uires suprarenal or supraceliac clamping, which has been
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operation poses additional problems and further increases
postoperative complication rates.4 Use of an infrarenal
proximal stent graft (ie, a cuff) can be a viable alternative
to open redo surgery in selected patients who still have
a suitable proximal landing zone.5 However, in most
patients, a suitable proximal neck is lacking, therefore pro-
hibiting standard endovascular aneurysm repair (EVAR).
Fenestrated EVAR (F-EVAR) is, meanwhile, an estab-
lished method in the treatment of short-necked and jux-
tarenal aneurysms. Reported studies show favorable early
and midterm outcomes.6-9 F-EVAR can be a viable alterna-
tive in the treatment of juxtarenal aneurysms after previous
standard EVAR.10 F-EVAR has also been used to treat
patients with proximal aortic pathology after surgical
reconstruction, although reported data are sparse.11,12
We have previously published our initial experience and
now report our midterm outcomes in 35 consecutive
patients 10 years after introduction of the method for
patients after failing open repair.13,14
METHODS
All patients with juxtarenal abdominal aortic aneurysms
(AAAs) after surgical aortic repair treated with F-EVAR307
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tion of the senior author (E.V.) were included in this study.
Data were collected prospectively. All patients had an
infrarenal neck length of #10 mm, precluding treatment
with a standard infrarenal device. The diameter of fenes-
trated grafts ranged from 22 to 36 mm to accommodate
proximal aortic diameters ranging from 20 to 32 mm.
Patients with insufﬁcient paravisceral ﬁxation or a thoracic
component to the aneurysmal degeneration were excluded
from the study. This is because of signiﬁcant differences in
stent graft design associated with the use of composite
thoracoabdominal, predominantly branched, stent grafts
in the latter category. Open redo surgery with renal artery
reimplantation was carried out in three patients with a jux-
tarenal aneurysm in the early study interval. From 2006, all
patients with juxtarenal aneurysms after surgical recon-
struction have been treated with F-EVAR. Preoperative
planning was carried out using thin cut (#1.5 mm) spiral
computerized tomography angiography (CTA) with axial,
coronal, and three-dimensional reconstructions. Additional
digital subtraction angiography (DSA) was performed
when there was indication that target or access vessel cath-
eterization could present difﬁculties. The physical status of
all patients was assessed preoperatively with the American
Society of Anesthesiologists (ASA) score.
All patients were treated with custom-made fenestrated
Cook endografts (William A. Cook Australia, Ltd, Bris-
bane, Australia) based on the Zenith system. A variety of
endograft conﬁgurations was used, to accommodate indi-
vidual patient anatomy. In the presence of adequate
working length of more than 5 cm from the lowest renal
artery to the aortic (neo)- bifurcation, a composite system
was preferably applied. In patients with too-short working
length, either a fenestrated cuff was used when adequate
sealing could be achieved within the previous graft or
a bifurcated fenestrated system (with a contralateral limb)
when distal landing in the iliac arteries was deemed
necessary.
Proximal graft scallops were 10 mm in width and 6 to
12 mm in depth. Since 2004, all scallops were reinforced
with nitinol around the perimeter. In the case of accessory
renal arteries, the decision to revascularize was determined
by the diameter of the artery and the amount of renal
volume depending on the vessel. Accessory renal arteries
with a diameter <3 mm were overstented. Fenestrations
were either 6 mm  6 mm or 6 mm  8 mm in size.
Initially, fenestrations were stented either with covered or
bare metal stents depending on whether the endograft
was in apposition to the aortic wall around the vessel
oriﬁce. Since 2007, all fenestrations were stented with
covered balloon-expandable stents. A variety of bare metal
and covered stents was applied for target vessels, reﬂecting
the evolution of the technique. The bare-metal stent used
in the beginning of the experience was the Genesis balloon-
expandable stent (Cordis, Warren, NJ) with diameters
ranging from 5 to 7 mm for the renal arteries and from 7
to 8 mm for the superior mesenteric artery (SMA). Length
was 29 or 39 mm for the renal arteries and 39 or 59 mmfor the SMA. The balloon-expandable covered stents
used were either Atrium iCAST (Atrium Medical Corpora-
tion, Hudson, NH) stent grafts or JOMED (JOMED
International AB, Helsingborg, Sweden) stent grafts. The
diameter of balloon-expandable covered stents ranged
from 5 to 7 mm for the renal arteries and 7 to 9 mm for
the SMA. The length of iCAST stent grafts was either 22
or 38 mm for renal arteries and 38 mm for the SMA.
JOMED stent grafts were 26 mm in length. Covered stents
were deployed aiming for protrusion of the stent graft of 3
to 4 mm into the body of the aortic graft. The portion
within the aortic graft was ﬂared using a 12-mm balloon
to achieve better sealing and to allow easier access to the
visceral vessel if future intervention were to be required.
In cases of severe angulation of the target vessel, an addi-
tional SMART (Cordis, Warren, NJ) or EVERFLEX (ev3
Inc, Plymouth, Minn) self-expandable bare-metal stent
was deployed inside the balloon-expandable covered stent
to prevent kinking.
Procedures were performed either in the operating
theater using a mobile C-arm (OEM 9800; General Elec-
tric Medical Systems, Salt Lake City, Utah, and Arcadis
Avantic; Siemens AG, Forchheim, Germany) or (later) in
a hybrid operating room with a ﬁxed C-arm system (Artis
Zeego; Siemens AG, Forchheim, Germany). The operative
technique has been described in detail previously.7,14 In
brief, femoral artery exposure is performed on both sides.
The fenestrated graft is introduced via the femoral artery
and unsheathed, leaving it partially constrained by its top
cap and diameter-reducing ties. Catheterization of the
fenestrations or branches is carried out through the contra-
lateral femoral artery. After wire access in all fenestrations
has been achieved, the graft is fully deployed. The fenestra-
tions are thereafter ﬁtted with stents or stent grafts. Finally,
in case of a composite fenestrated system, the distal bifur-
cated body is introduced and deployed.
Technical success was deﬁned as an endovascularly
completed procedure with absence of type I or III endo-
leak and patent target vessels.
Follow-up (FU). Postoperatively, patients were evalu-
ated with clinical and laboratory examination prior to
discharge. FU consisted of CTA at 1 month, duplex ultra-
sound (DUS) at 6 months, and CTA at 12 months postop-
eratively. Thereafter, patients were monitored with yearly
CTA or solely with DUS and abdominal X-rays in case of
complete thrombosis of the aneurysm sack and absence
of endoleak. Renal size measurements were carried out
on CTA three-dimensional reconstruction images as well
as DUS examinations. Renal vessels were investigated for
stenosis by means of CTA with planar reconstruction as
well as DUS with peak systolic velocity and renal aortic
ratio measurements. Upon suspicion of a new endoleak or
target vessel malperfusion, DSA was carried out. Serum
creatinine and glomerular ﬁltration rate (GFR) levels were
monitored at each visit.
Data analysis. Data analysis was performed with SPSS
for Windows (version 20.0; SPSS Inc, Chicago, Ill). Vari-
ables are presented as mean 6 standard deviation in case
Table I. Target vessel revascularization method
Target vessel
Fenestration type
TotalFenestration Scallop Branch
RRA 32 2 0 34
LRA 31 0 1 32
SMA 14 19 0 33
CA 0 12 0 12
Total 77 33 1 111
CA, Celiac artery; LRA, left renal artery; RRA, right renal artery; SMA,
superior mesenteric artery.
Table II. Stent graft conﬁguration with fenestration
speciﬁcation for each vessel
Patients, No. (%)
Fenestration conﬁguration
RRA LRA SMA CA
18 (51.4) Fen Fen Scallop 0
10 (28.5) Fen Fen Fen Scallop
1 (2.9) Fen Occl Fen Scallop
1 (2.9) Fen Branch Y Fen Scallop
1 (2.9) Fen Fen Fen 0
1 (2.9) Scallop Fen Scallop 0
1 (2.9)a 0 0 Fen Occl
1 (2.9) Fen 0 0 0
1 (2.9) Scallop Fen 0 0
CA, Celiac artery; Fen, fenestration; LRA, left renal artery; Occl, chronically
occluded; RRA, right renal artery; SMA, superior mesenteric artery.
aPatient with bilateral nephrectomy and CA occlusion.
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a skewed distribution. Statistical signiﬁcance was set at
P < .05. Patient survival and target vessel patency was
analyzed using Kaplan-Meier methodology.
RESULTS
Patient characteristics. A total of 35 patients (33
male, 2 female; mean age, 71.5 6 6.2 years) underwent
elective F-EVAR for juxtarenal AAA after previous infrare-
nal surgical reconstruction. Twenty-two (62.9%) patients
were classiﬁed as ASA III, 12 (34.3%) patients as ASA II,
and 1 (2.9%) patient was classiﬁed as ASA IV. Mean
preoperative GFR was 52.6 6 15.7 mL/min/1.73 m2.
Thirteen (37.1%) patients had a GFR <60 mL/min/
1.73 m2. Other pre-existing comorbidities included coro-
nary artery disease in 25 (71.4%) patients, congestive heart
failure in 8 (22.8%) patients, obstructive pulmonary disease
in 10 (28.5%) patients, and peripheral arterial occlusive
disease in 4 (11.4%) patients.
Median interval from the primary surgical reconstruction
was 126 months (range, 48-223 months). Twenty-three
(65.7%) patients had been treated with a tube graft and eight
(22.9%) with an aortobiiliac (ABI) graft. The four (11.4%)
patients with concomitant peripheral occlusive disease had
previously been treated with an aortobifemoral (ABF) graft.
Four of the patients had two previous operations. These
included a tube graft followed by another tube graft for
a distal anastomotic pseudoaneurysm in two cases, a tube
graft followed by an ABI graft in the third patient, and
a left iliac stent graft placed for a distal anastomotic pseudoa-
neurysm after an ABI graft in the fourth patient.
Mean maximal aneurysm diameter was 60 6 4 mm,
and mean infrarenal aortic neck length was 1 6 2 mm.
Mean aortic diameter in the pararenal segment was 28 6
4 mm. In 14 (40%) patients, indication for treatment was
a PAA originating below the level of the renal arteries indi-
cating possible graft-related pseudoaneurysm formation,
whereas in 21 (60%) patients, the aneurysmal degeneration
encroached on the visceral segment, indicating a proximal
progression of disease.
Operative planning and details. A fenestrated cuff
was used in 9 (25.7%) patients, a bifurcated fenestrated
graft in 2 (5.7%) patients, and a composite fenestrated
system in 24 (68.6%) patients. Mean proximal diameter
of the fenestrated graft was 30 6 4 mm, and mean limb
diameter was 16 6 4 mm. In one case, the composite
system included a Zenith (William A. Cook Australia,
Ltd) iliac branched endograft to accommodate an aneu-
rysm of the right common iliac artery. In total, 111 visceral
vessels were targeted, 77 with fenestrations, 33 with scal-
lops, and 1 vessel with a downward branch. The target
vessel revascularization method is demonstrated in
Table I. In 21 (60%) patients, the stent graft was
designed to reach the level of the SMA, with the most
commonly used conﬁguration in 18 patients including two
fenestrations for the renal arteries and a scallop for the
SMA. A stent graft including a scallop for the celiac artery
was designed in 12 (34.3%) patients. In two (5.7%)patients, the fenestrations targeted solely the renal oriﬁces.
The graft fenestration conﬁgurations used are listed in
Table II.
Scallops were routinely left unstented, with the excep-
tion of one patient where deployment of a bare stent was
required due to partial coverage of the renal oriﬁce. Fenes-
trations were secured with balloon-expandable covered
stents in 62/77 (80.5%) cases and with balloon-
expandable bare-metal stents in 11/77 (14.3%) cases. In
the remaining four (5.1%) cases, a combination of
a balloon-expandable covered and a self-expandable bare-
metal stent was applied. The one vessel targeted with
a branch was secured with a self-expandable covered and
a self-expandable bare-metal stent.
The procedure was carried out under general anes-
thesia in 29 (82.9%) patients and under epidural anesthesia
in six (17.1%) patients. Median operative time was
210 minutes (range, 110-420 minutes), and median esti-
mated blood loss was 265 mL (range, 100-1500 mL).
Median ﬂuoroscopy time was 41 minutes (range, 8-
140 minutes), and mean iodinated contrast volume used
was 180 6 54 mL.
Technical success. All patients underwent a successful
endovascular repair. In 33 patients (94.2%), F-EVAR was
completed solely via a transfemoral approach. In one
patient (2.9%), a planned retroperitoneal incision was
Fig 1. Spiral computerized tomography angiography (CTA) in
axial (A) and three-dimensional reconstruction (B) views
demonstrating a stenotic angulated left renal artery with an ante-
rior take-off, catheterized via a retroperitoneal approach.
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angulated, and tortuous left renal artery with an anterior
take-off (Fig 1). This patient had undergone additional
preoperative DSA via a transfemoral and a transbrachial
approach, which demonstrated that the left renal artery was
not susceptible to antegrade catheterization. Following
exposure of the distal portion of the left renal artery, a 5Fsheath was introduced into the vessel. The fenestration was
catheterized in a retrograde manner, and the wire was
snared to create a through-and-through wire, to allow for
safe stenting. In the second patient, a transbrachial app-
roach was necessary to achieve catheterization of a caudally
oriented branch for a severely tortuous left renal artery with
aneurysmal, caudally oriented take-off.
Intraoperative technical problems were encountered in
nine (25.7%) patients. In one (2.9%) patient, a dense peri-
prosthetic scar led to a difﬁcult exposure of the ABF limb,
and direct access through the Dacron graft limb was poorly
hemostatic, leading to a large amount of intraoperative
blood loss (1500 mL). In another patient, high deployment
of the stent graft resulted in malalignment of the fenestra-
tions with the target vessels. During attempts to pull the
endograft downward, the bottom stent was deformed,
which required placement of a distal aortic cuff. In the
remaining seven (14.2%) patients, renal artery catheteriza-
tion and stent graft deployment were problematic due to
severe stenosis and angulation. In two of these cases, passage
of a JOMED stent graft into the right renal artery resulted in
the stent graft being pushed off of the balloon. Both stents
were successfully retrieved and replaced. In the third patient
with a severely angulated right renal artery originating from
the PAA, catheterization proved extremely tedious and was
ultimately achieved with a 0.01800 Terumo wire (Terumo
Medical Corporation, Somerset, NJ). After introduction
of a 7F sheath, the fenestrated graft was deployed
completely to create more working room, and the oriﬁce
of the renal artery was predilated with a STERLING balloon
(Boston Scientiﬁc PI, Natick, Mass). The vessel was secured
with a balloon-expandable covered iCAST stent and addi-
tional deployment of a self-expandable SMART stent to
prevent kinking. The same stent combination was applied
in two more patients with angulated renal arteries and in
the sixth patient with problematic target vessel anatomy
due to a short dissection of the left renal artery during cath-
eterization. Finally, the seventh case involved the patient
treated with a caudally oriented branch. The left renal artery
was severely tortuous, had to be revascularised from a left
axillary access, and was secured with a Wallgraft (Boston
Scientiﬁc PI) and an Everﬂex bare-metal stent (EV3 Endo-
vascular, Inc).
Operative outcome, mortality, and morbidity.
Surgical mortality at 30 days was null. No case of renal
function deterioration >30% was witnessed in the early
postoperative period. Mean postoperative GFR was
51.7 6 15.7 mL/min/1.73 m2. Major complications
occurred in three (8.6%) patients. The patient who under-
went retroperitoneal approach suffered a decompensation
of his congestive heart failure with a subsequent myocardial
infarction and a prolonged hospital stay of 23 days. A
second patient suffered a non-ST segment elevation
myocardial infarction on the second postoperative day.
Coronary angiography demonstrated no relevant coronary
artery stenosis, and the incident was attributed to vaso-
spasm. The patient had a 17-day hospital stay. Both
patients were discharged in good condition. The third
Fig 2. Kaplan-Meier estimate of the cumulative overall patient
survival for all-cause mortality during follow-up (FU).
Time, months 12 24 36 48 60
Number at risk 21 18 16 11 6
Standard error 0.055 0.079 0.079 0.093 0.129
Fig 3. Kaplan-Meier estimate of target vessel patency during
follow-up (FU).
Time, months 12 24 36 48 60
Number at risk 65 56 47 33 17
Standard error 0.012 0.023 0.023 0.023 0.023
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hospital stay of 40 days for wound care, due to the exis-
tence of an ABF graft in the groin.
Median hospital stay was 6 days (range, 2-40 days).
Treatment in the intensive care unit was necessary solely
in the two patients with MI for 9 and 2 days, respectively.
FU. Mean FU was 37.5 6 25 months. Two patients
who were referred from abroad were lost to FU after their
1-year FU. Estimated survival rates were 92.0% 6 5.5%,
82.8% 6 7.9%, and 76.9% 6 9.3% at 1, 2, and 4 years,
respectively. Fig 2 demonstrates the cumulative survival
curve as estimated by Kaplan-Meier analysis. All-cause late
mortality was eight patients, all of them aneurysm
unrelated.
During FU, three cases of renal artery occlusion
occurred. One patient presented with an asymptomatic
right renal artery occlusion at 6 months. This vessel had
been targeted with an unsupported scallop and left
unstented. No graft migration or kinking that could
explain the occlusion was detected on CTA. A second
patient presented at 8 months with bilateral occlusion of
the renal arteries, originally secured with JOMED covered
stents. The patient had unremarkable CTAs at 1 and
6 months and suffered the occlusion after traveling abroad
and suffering severe gastroenteritis with volume depletion.
This patient presented for FU after dialysis had been initi-
ated in an external hospital. In the remaining 34 (97.1%)
patients, renal function and kidney size remainedunchanged during FU. No hemodynamically signiﬁcant
visceral branch stenosis was visualized in DUS. Mean
GFR during FU was 52.8 6 12.8 mL/min/1.73 m2. Esti-
mated target vessel patency according to Kaplan-Meier
analysis is demonstrated in Fig 3.
No limb occlusion or stent graft migration was wit-
nessed during FU. No reinterventions were required.
Mean maximal aneurysm diameter decreased from
60.1 6 4 mm to 47.3 6 8 mm (P < .05).
DISCUSSION
Open infrarenal repair of AAAs is generally associated
with a lower need for reinterventions than EVAR.15
Although proximal aneurysm formation has been reported
in only 3% of patients, it nevertheless poses signiﬁcant tech-
nical problems when considering renewed open repair.16
The challenges associated with conventional abdominal
aortic redo surgery are considerable and related to
increased mortality and morbidity rates, especially when
the pararenal segment is involved.3,17-19 Suprarenal aortic
clamping has been shown to signiﬁcantly increase postop-
erative renal morbidity.20 Treatment with standard infrare-
nal devices can offer an attractive and potentially durable
alternative in selected patients, although literature up to
now contains relatively few and limited reports.21-23 A
recent study from Ten Bosch et al demonstrated a consider-
able rate of proximal type I endoleaks and need for reinter-
ventions in patients with proximal PAAs treated with
Fig 4. Angiographic images depicting partial deployment of the fenestrated graft (a and b) to facilitate cannulation of
the renal arteries and the fully deployed graft (c and d) with deployed renal stents.
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durable in the presence of suitable anatomy.5
The present series suggests that F-EVAR can offer
a safe and effective alternative in patients with proximal
neck anatomy precluding treatment with standard endo-
vascular means. Operative mortality was null, and perio-
perative morbidity was low in this patient cohort.
Hospital stay was lower compared with reported dataregarding redo-open surgery.23 Target vessel patency
remained high during FU, and no reinterventions were
needed during midterm FU. F-EVAR led to a signiﬁcant
decrease in maximal aneurysm diameter. To our knowl-
edge, this is the largest study in the literature, with
the longest FU on F-EVAR after previous infrarenal
surgical reconstruction. Apart from previous reports by
the same main author, there are only two papers
JOURNAL OF VASCULAR SURGERY
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three patients, respectively.11-14
Despite the high technical success in this series, addi-
tional difﬁculties in planning and execution of the proce-
dure have to be expected when attempting F-EVAR after
previous open surgery. Primary F-EVAR nowadays
routinely utilizes composite systems consisting of a fenes-
trated proximal tube graft, which can be freely repositioned
facilitating target vessel catheterization, followed by a bifur-
cated stent graft, and a contralateral limb. This conﬁgura-
tion provides additional graft stability and is effective in
preventing migration. This conﬁguration is, however, often
not applicable in patients previously treated with ABI grafts
or ABF grafts due to the usual practice of implanting a short
graft body. In cases with a working length too short for
a composite system, sealing is achieved solely with a fenes-
trated proximal cuff. No case of stent graft migration
during FU was noticed in the nine (25.7%) patients treated
solely with proximal cuffs, but additional surveillance is
required to prove the durability of this conﬁguration.
Furthermore, the presence of a previous surgical graft
clearly limits maneuverability during deployment of the
fenestrated device, due to the relatively small luminal diam-
eter of the surgical prosthesis and the frictional forces
between the endovascular and surgical graft. Catheteriza-
tion of target vessels can be problematic under these
circumstances and may require the use of multiple types
of catheters and sheaths, or even a retrograde puncture in
rare cases. It is furthermore imperative to avoid deploying
the fenestrated tube too high, as pulling down the graft
in an existing surgical graft is tedious and sometimes not
possible. To facilitate repositioning, fenestrated devices
are designed to only partially deploy upon retraction of
the delivery sheath. The fenestrated tube graft is restrained
by incorporated diameter reducing ties, which are removed
after successful catheterization of the visceral branches. To
accommodate catheterization maneuvers in cases of small
luminal diameter of the preexisting graft, double preplaced
diameter-reducing restraining ties can be applied. Fig 4
demonstrates a fenestrated graft prior to and following
removal of its restraining ties.
Finally, arterial access issues are often encountered in
patients with a previous ABF graft. Direct puncture of
the ABF limb can result in increased blood loss around
the sheaths. Our current practice is to introduce the device
through a conduit sewn on the ABF limb. Upon comple-
tion of the intervention, the conduit is sewn closed.
This series reﬂects some of the changes that have taken
place in the design of fenestrated endografts since the
introduction of this technique. Since 2004, all scallops
have been reinforced with nitinol around the perimeter,
due to an association of unsupported scallops with vessel
stenosis (unpublished data). Similarly, the use of uncovered
stents for fenestrations has been abandoned due to an asso-
ciation of uncovered stents with higher rates of stent
stenosis. This association was based upon previous unpub-
lished experience and expert consensus meetings in the
early days of fenestrated endografting and was laterconﬁrmed by Mohabbat et al.24 Finally, this series features
one patient treated with a single fenestration for a renal
artery and one patient with a fenestration for one renal
artery and a scallop for the second. These patients were
treated early in the series and had one renal artery that
was signiﬁcantly higher than the other. Nowadays, the
use of scallops for renal arteries is not advocated. Two
fenestrations is the preferable way of treatment to ensure
better graft stability.
This study has some limitations. The number of
patients is limited. This is a selected patient population,
and a certain referral bias has to be acknowledged. Finally,
this study reﬂects the outcomes of two high-volume
centers for F-EVAR.
CONCLUSIONS
F-EVAR is a valid treatment method in cases of PAAs
or progressive juxtarenal aneurysmal degeneration after
open repair. Although additional technical difﬁculties in
comparison to primary F-EVAR in the native aorta should
be acknowledged, it clearly represents a less morbid alter-
native to open conversion, has a high technical success
rate, and has durability in midterm FU.
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